PDCD1 and cancer: Furthermore, recent research into other types of cancer obtained promising results by combining traditional PD-1/PD-L1-inhibiting therapy with other immunotherapeutic approaches, such as CAR T-cells [80] or inhibition of other inhibitory immune checkpoints [81,82].